MarketPulse
I

$IVBIY

2 articles found
2 positive
0 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

GLP-1 Drug Market Poised to Triple to $202B by 2033 Amid Obesity Surge

Global GLP-1 receptor agonist market projected to grow from $70B in 2025 to $202B by 2033 at 12.78% annual rate, driven by obesity and diabetes prevalence.
LLYSNYNVOAZNIVBIYclinical trialsmarket growth
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

CTLA-4 Inhibitor Pipeline Expands With 50+ Candidates in Development Across 40+ Companies

Over 40 companies develop 50+ CTLA-4 inhibitor candidates for cancer immunotherapy. Recent FDA approvals and focus on combination strategies drive pipeline expansion.
BMYCELGrAZNIVBIYAGEN+1FDA approvalclinical trials